DocGo to announce Q2 2026 results on Aug 17

1 min read     Updated on 10 Aug 2026, 06:13 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

DocGo Inc will announce its Q2 2026 financial results after market close on August 17, 2026. A conference call and webcast are scheduled for 5:00 p.m. ET to discuss the quarter's performance.

powered bylight_fuzz_icon
47911402

*this image is generated using AI for illustrative purposes only.

DocGo Inc (NASDAQ: DCGO) will release its financial results for the second quarter ended June 30, 2026, after markets close on Monday, August 17, 2026. The technology-enabled mobile health and medical transportation services provider will also host a conference call to discuss these results at 5:00 p.m. ET on that day.

Conference Call Details

Management will host a conference call and webcast to discuss the quarterly performance. The event is scheduled for Monday, August 17, 2026, at 5:00 p.m. ET.

Detail Information
Date August 17, 2026
Time 5:00 p.m. ET
U.S. Dial-in 1-800-717-1738
International 1-646-307-1865
Conference ID 78516

Investors can access the Call me™ feature to avoid waiting for an operator by clicking the link provided in the company’s investor relations materials. A webcast of the conference call will be available under Events on the Investors section of DocGo’s website at https://ir.docgo.com/ .

About DocGo

DocGo operates a care delivery platform that includes mobile health services, remote patient monitoring, ambulance services, and a 50-state virtual care network. The company aims to reshape traditional healthcare systems by providing accessible care through its proprietary technology and field staff of certified health professionals.

How might DocGo's Q2 2026 revenue growth trajectory influence its valuation relative to other telehealth and mobile health competitors?

Will the company provide updated guidance on the expansion of its 50-state virtual care network for the remainder of 2026?

What impact could changes in Medicare or Medicaid reimbursement policies have on DocGo's profitability in upcoming quarters?

like17
dislike

DocGo granted additional 180-day Nasdaq extension through Jan. 25, 2027

0 min read     Updated on 01 Aug 2026, 01:49 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

DocGo secures an 180-day extension from Nasdaq to restore compliance with listing rules. The company must demonstrate adherence to exchange requirements by January 25, 2027, to maintain its listing status and avoid further regulatory proceedings.

powered bylight_fuzz_icon
47074730

*this image is generated using AI for illustrative purposes only.

DocGo has been granted an additional 180-day extension by the Nasdaq Stock Market to regain compliance with its listing requirements. The extension provides the company with a new deadline of January 25, 2027, to demonstrate that it meets the necessary standards for continued listing on the exchange.

The announcement confirms that DocGo will have this additional period to address the compliance issues that initially triggered the review process. This timeframe allows the company to implement corrective measures and submit evidence of compliance to the exchange before the final deadline.

Compliance Timeline

Milestone Date
Extension Deadline January 25, 2027

The extension is a standard procedural step in the Nasdaq delisting prevention process, giving companies a defined window to resolve deficiencies. Failure to regain compliance by the specified date could result in further regulatory actions, including potential delisting hearings.

What specific financial or operational metrics must DocGo meet to satisfy Nasdaq's listing requirements by the January 2027 deadline?

How might this extended compliance period impact DocGo's ability to secure new financing or attract institutional investors in the interim?

Are there any strategic partnerships or restructuring plans DocGo has announced that could help it regain compliance within this 180-day window?

like15
dislike

More News on DocGo Inc